Not exact matches
Looking to target a key pathway in order to interfere
with the processes that lead to
tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and
other malignant
solid tumors.
Purushotham points out, «The feasibility of intraoperative CLI as shown in this study, in combination
with the wide applicability of F -18-FDG across a range of
solid cancers, provides a stepping stone for clinical evaluation of this technology in
other solid cancer types that also experience incomplete
tumor resection due to close or involved margins.»
Although breast cancer was the initial focus and featured in the study published online today, the team has also conducted experiments
with other types of
solid tumors,
with similar results.
Our integrated approach is speeding the development of new and better immunotherapies for patients
with solid tumor cancers, blood cancers and
other non-cancerous disorders.
To understand why this occurs, they examined the effect of a CDK4 / 6 inhibitor called abemaciclib in mice
with breast or
other solid tumors.
The Bone Marrow and Stem Cell Transplant Program is expanding the use of this technique for patients
with solid tumors including neuroblastoma and brain
tumors; a variety of high - risk hematologic diseases, such as thalassemia major and transfusion - dependent sickle cell disease; and
other nonmalignant diseases.
Many people suffering
with cancer and diseases associated
with immune dysfunction, such as lymphoma, leukemia, multiple myeloma,
solid tumors, recurrent infections, neurodegenerative disorders and
other chronic diseases, have turned to the Maharaj Institute in the hope of finding a more favorable prognosis and better quality of life.
Patients
with hematological malignancies are at a particularly higher risk of developing severe infections when compared to
other patients
with solid tumors and the population in general.
At the
Solid Tumor Oncology Program, part of C.S. Mott Children's Hospital at the University of Michigan, we provide comprehensive, multidisciplinary care for children with Wilm's tumor and other renal masses or kidney tu
Tumor Oncology Program, part of C.S. Mott Children's Hospital at the University of Michigan, we provide comprehensive, multidisciplinary care for children
with Wilm's
tumor and other renal masses or kidney tu
tumor and
other renal masses or kidney
tumors.
At the
Solid Tumor Oncology Program, part of C.S. Mott Children's Hospital at the University of Michigan, we provide comprehensive, multidisciplinary care for children
with hepatoblastoma and
other liver
tumors such as hepatocarcinoma, hepatic adenoma and hamartomas.
The multikinase angiogenesis inhibitor pazopanib was well tolerated and exhibited some responses in pediatric patients
with soft - tissue sarcomas and
other refractory
solid tumors in a phase I trial.
Unlike
solid tumor cancers, leukemia and
other blood cancers (most lymphomas) can not be treated
with surgery, and radiation is used rarely in special circumstances, such as before a transplant, Dr. Mattison says.